Post-myocardial Infarction

A myocardial infarction (heart attack) causes lasting damage to heart muscle. The weeks and months that follow are a critical window: the right treatment started early can significantly lower the chance of another event, slow further heart damage, and improve long-term quality of life.

Medicines used to treat Post-myocardial Infarction

Tritace

Ramipril

1.25 · 2.5 · 5 · 10mg

Developed to manage high blood pressure and to support heart health by inhibiting the angiotensin-converting enzyme.

From $0.61 / tablet View

Altace

Ramipril

1.25 · 2.5 · 5 · 10mg

Utilized to support cardiac function and indicated to mitigate high blood pressure and post-heart attack complications.

From $0.58 / tablet View

Protecting the heart after a heart attack

Post-MI management typically combines several approaches working together. ACE inhibitors such as ramipril are a cornerstone, they reduce the workload on the heart, help prevent the left ventricle from enlarging, and have been shown to cut mortality after MI. Alongside these, most people also take medicines to control blood pressure, reduce clot risk, and manage cholesterol. Full guidance on this class of medicines sits in the heart and blood pressure section of the catalogue.

Lifestyle adjustments run parallel to medicines: a diet low in saturated fat and salt, structured cardiac rehabilitation where available, avoiding smoking, and gradually rebuilding physical activity under medical supervision. Across South and Southeast Asia, cardiac rehabilitation programmes are growing in major centres, though access varies significantly between urban hospitals and community settings.

Chest pain, severe breathlessness, or irregular heartbeat after a heart attack warrant urgent medical attention, do not wait.